Evidence map›Paper›PMID 42287064›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026

[Bone marrow infiltration of large B-cell lymphoma with clinical manifestations similar to systemic lupus erythematosus: A case report].

Doudou Ma, Xiaocai Ma, Tianjing Chang, Lifang Wang, Yan Ding, Lianjie Shi

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Doudou MaDepartment of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.
Xiaocai MaDepartment of Hematology, Peking University Shougang Hospital, Beijing 100144, China.
Tianjing ChangDepartment of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Lifang WangDepartment of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.
Yan DingDepartment of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.
Lianjie ShiDepartment of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) and lymphoma are two different diseases. However, they might mimic each other sometimes. Here, we reported a case of bone marrow infiltration as initial manifestation of large B-cell lymphoma that mimiced SLE. The patient was an elderly female whose chief complaints were edema and bilateral lower limb fatigue for one month. Initially, she was prescribed thyroid hormone supplementation and albumin infusion for hypothyroidism and hypoproteinemia, respectively. The edema was improved, but fatigue worsened and the patient was bedridden. Then further examinations revealed anemia, thrombocytopenia, elevated lactate dehydrogenase (LDH), abnormal coagulation function, positive urinary protein, reduced complement C3 and C4, and positive antinuclear antibodies. Based on the above manifestations and laboratory findings, the diagnosis of SLE was considered. After administering 40 mg/d of methylprednisolone, the patient' s edema, platelet count and LDH levels were improved, whereas her fatigue worsened to the point where she had difficulty turning in bed. When the dose of glucocorticoid tapered to 40 mg/d of prednisone, the LDH levels elevated and platelet counts decreased. The treatment response was inconsistent with SLE. In order to clarify and confirm the diagnosis, bone marrow puncture was performed and showed large B-cell lymphoma with bone marrow infiltration of 27.5% tumor cells. Enlargement of superficial lymph node or visceral organ is common clinical manifestation of lymphoma. However, our present case was bone marrow infiltration lonely without enlargement of lymph node and organ, and it is referred to as bone marrow lymphoma (BML). BML can be classified into primary bone marrow lymphoma (PBML) and secondary bone marrow lymphoma (SBML). PBML is a rare and primary tumor in the bone marrow without involvement of lymph nodes, liver, spleen and any other organs. It is easy to be misdiagnosed or missed diagnosis due to the absence of specific clinical presentation. Bone marrow examination is required and important to make the diagnosis of PBML. Diffuse large B-cell lymphoma is the most common type of PBML. SBML is caused by lymphoma in other parts of the body and invasion of bone tissue. Most of BML patients have a poor prognosis and require rapid diagnosis and treatment. The patient we reported only took two months from onset of symptoms to death. This case indicated that it was crucial to revisit the diagnostic and therapeutic strategies when treatment response was not consistent with the diagnosis.

Indexed as

Bone MarrowLupus Erythematosus, SystemicLymphoma, Large B-Cell, DiffuseAgedDiagnosis, DifferentialFemaleHumansB-cell lymphomaDifferential diagnosisEdemaFatigueSystemic lupus erythematosus

Identifiers

PMID42287064
PMCPMC13268848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.